Moderna COVID-19 Vaccine Authorized For Emergency Use In India: What You Need To Know
Moderna, Inc.'s (NASDAQ: MRNA) COVID-19 vaccine should soon find its way into India, one of the countries worst affected by the second
Moderna’s COVID-19 Vaccine Produced Neutralizing Titers Against All Variants Tested
Moderna Inc (NASDAQ:MRNA) has announced new results from in vitro neutralization studies of sera from individuals vaccinated with its COVID-19 vaccine.…
India Made AstraZeneca’s COVID-19 Vaccine Not Eligible For EU Travel, Seeks Resolution: Reuters
Serum Institute of India’s (SII) CEO Adar Poonawalla said he was trying to resolve EU travel problems facing Indians inoculated…
UK Study Of COVID-19 Shots Mix-Match Shows Immune Response, Can Add Flexibility To Vaccination Programs: CNBC
Mixing and matching the coronavirus vaccines made by Pfizer Inc (NYSE:PFE) – BioNTech SE (NASDAQ:BNTX) and AstraZeneca Plc (NASDAQ:AZN) – Oxford showed a “robust”…
AstraZeneca COVID-19 Vaccine Shows Higher Immune Response With Longer Gap, Third Booster Dose
A sub-analysis from the Oxford-led COV001 and COV002 trials with AstraZeneca Plc (NASDAQ:AZN) COVID-19 vaccine induced strong immune responses following a prolonged second…
AstraZeneca Kick-Starts New COVID-19 Variant Vaccine Trial
AstraZeneca Plc (NASDAQ:AZN) has started testing its new COVID vaccine, dubbed AZD2816, a tweaked version using the same platform as…
AstraZeneca’s Nirsevimab Shows Favorable Safety, Tolerability Profile In Infants At High Risk Of RSV
AstraZeneca Plc (NASDAQ: AZN) announced data from the MEDLEY Phase 2/3 trial evaluating nirsevimab in infants at high risk of respiratory syncytial virus (RSV).